X-151623027-T-C
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_173493.3(PASD1):c.509T>C(p.Val170Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000019 in 1,207,644 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173493.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000896 AC: 1AN: 111652Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000330 AC: 6AN: 181979 AF XY: 0.0000301 show subpopulations
GnomAD4 exome AF: 0.0000201 AC: 22AN: 1095992Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 5AN XY: 361554 show subpopulations
GnomAD4 genome AF: 0.00000896 AC: 1AN: 111652Hom.: 0 Cov.: 23 AF XY: 0.0000296 AC XY: 1AN XY: 33816 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.509T>C (p.V170A) alteration is located in exon 7 (coding exon 6) of the PASD1 gene. This alteration results from a T to C substitution at nucleotide position 509, causing the valine (V) at amino acid position 170 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at